Stoke Therapeutics, Inc. (STOK): 8-K filed Jun 30, 2026

Form type

8-K

Filing date

Jun 30, 2026

Accession number

0001193125-26-289409

Filer

Stoke Therapeutics, Inc. (CIK 1623526)